Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biolife Solutions Inc (BLFS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biolife Solutions Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 834365.
Total stock buying since 2015: $90,394,916.
Total stock sales since 2015: $275,940,648.
Total stock option exercises since 2015: $4,836,362.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,097,226 | $49,630,348 | 0 | $0 |
| 2024 | 0 | $0 | 231,256 | $4,893,616 | 40,000 | $82,400 |
| 2023 | 1,135,630 | $14,414,917 | 334,430 | $6,200,408 | 165,678 | $331,532 |
| 2022 | 0 | $0 | 409,313 | $9,471,705 | 362,642 | $276,930 |
| 2021 | 0 | $0 | 1,427,462 | $58,822,192 | 1,021,156 | $1,275,803 |
| 2020 | 4,971,536 | $75,363,459 | 5,524,349 | $113,790,368 | 641,176 | $1,233,313 |
| 2019 | 40,000 | $616,540 | 1,112,177 | $18,396,379 | 688,589 | $1,154,913 |
| 2018 | 0 | $0 | 1,793,804 | $14,735,632 | 254,250 | $338,044 |
| 2017 | 0 | $0 | 0 | $0 | 113,570 | $134,019 |
| 2016 | 0 | $0 | 0 | $0 | 7,142 | $7,006 |
| 2015 | 0 | $0 | 0 | $0 | 2,143 | $2,402 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-18 | De Greef Roderick (COO & President) | Sale | 7,000 | 50.75 | 355,250 |
| 2021-11-17 | Mathew Aby J. (EVP & Chief Scientific Officer) | Sale | 10,000 | 51.07 | 510,700 |
| 2021-11-17 | Mathew Aby J. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-11-17 | De Greef Roderick (COO & President) | Sale | 7,000 | 51.08 | 357,560 |
| 2021-11-16 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 50.63 | 311,880 |
| 2021-11-16 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-11-16 | De Greef Roderick (COO & President) | Sale | 7,000 | 51.39 | 359,730 |
| 2021-11-15 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 47.96 | 295,433 |
| 2021-11-15 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-11-15 | Mathew Aby J. (EVP & Chief Scientific Officer) | Sale | 10,000 | 48.11 | 481,100 |
| 2021-11-15 | Mathew Aby J. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-11-09 | Schulz Marcus (Chief Revenue Officer) | Sale | 1,750 | 53.00 | 92,750 |
| 2021-11-04 | Rice Michael (CEO) | Sale | 11,461 | 56.81 | 651,099 |
| 2021-11-04 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-11-02 | Rice Michael (CEO) | Sale | 11,461 | 54.72 | 627,145 |
| 2021-11-02 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-10-25 | Foster Karen A. (Chief Quality Officer) | Sale | 16,332 | 44.45 | 725,957 |
| 2021-10-25 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,332 | 1.64 | 26,784 |
| 2021-10-25 | De Greef Roderick (Chief Financial Officer) | Sale | 2,371 | 44.62 | 105,794 |
| 2021-10-20 | Aebersold Sarah (VP, Global Human Resources) | Sale | 272 | 42.34 | 11,516 |
| 2021-10-20 | Schulz Marcus (Chief Revenue Officer) | Sale | 399 | 42.34 | 16,893 |
| 2021-10-20 | Mathew Aby J. (EVP & Chief Scientific Officer) | Sale | 10,000 | 41.97 | 419,700 |
| 2021-10-20 | Mathew Aby J. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-10-18 | Mathew Aby J. (EVP & Chief Scientific Officer) | Sale | 10,000 | 41.34 | 413,400 |
| 2021-10-18 | Mathew Aby J. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-10-15 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 40.76 | 251,081 |
| 2021-10-15 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-10-14 | Foster Karen A. (Chief Quality Officer) | Sale | 1,082 | 39.97 | 43,247 |
| 2021-10-14 | Berard Todd (Chief Marketing Officer) | Sale | 7,055 | 39.91 | 281,600 |
| 2021-10-14 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-10-14 | Mathew Aby J. (EVP & Chief Scientific Officer) | Sale | 1,273 | 39.97 | 50,881 |
| 2021-10-14 | Rice Michael (CEO) | Sale | 3,215 | 39.97 | 128,503 |
| 2021-10-14 | De Greef Roderick (Chief Financial Officer) | Sale | 1,221 | 39.97 | 48,803 |
| 2021-10-11 | Schulz Marcus (Chief Revenue Officer) | Sale | 245 | 38.22 | 9,363 |
| 2021-10-07 | Schick Joseph C (Director) | Sale | 3,250 | 40.11 | 130,347 |
| 2021-10-07 | Rice Michael (CEO) | Sale | 11,461 | 40.55 | 464,743 |
| 2021-10-07 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-10-05 | Rice Michael (CEO) | Sale | 11,461 | 40.63 | 465,660 |
| 2021-10-05 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-09-28 | Foster Karen A. (Chief Quality Officer) | Sale | 610 | 43.12 | 26,303 |
| 2021-09-28 | Berard Todd (Chief Marketing Officer) | Sale | 505 | 43.12 | 21,775 |
| 2021-09-28 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 719 | 43.12 | 31,003 |
| 2021-09-28 | Rice Michael (CEO) | Sale | 907 | 43.12 | 39,109 |
| 2021-09-28 | De Greef Roderick (CFO) | Sale | 689 | 43.12 | 29,709 |
| 2021-09-27 | Foster Karen A. (Chief Quality Officer) | Sale | 16,332 | 44.66 | 729,387 |
| 2021-09-27 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,332 | 1.64 | 26,784 |
| 2021-09-22 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 46.99 | 469,900 |
| 2021-09-22 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-09-20 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 46.89 | 468,900 |
| 2021-09-20 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-09-16 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 46.10 | 283,976 |
| 2021-09-16 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-09-15 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 49.01 | 301,901 |
| 2021-09-15 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-09-09 | Rice Michael (CEO) | Sale | 11,461 | 52.59 | 602,733 |
| 2021-09-09 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-09-07 | Rice Michael (CEO) | Sale | 11,461 | 52.50 | 601,702 |
| 2021-09-07 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-08-27 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 399 | 57.26 | 22,846 |
| 2021-08-26 | Foster Karen A. (Chief Quality Officer) | Sale | 325 | 57.26 | 18,609 |
| 2021-08-26 | Rice Michael (CEO) | Sale | 848 | 57.26 | 48,556 |
| 2021-08-25 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 53.12 | 531,200 |
| 2021-08-25 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-08-23 | Foster Karen A. (Chief Quality Officer) | Sale | 16,332 | 46.54 | 760,091 |
| 2021-08-23 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,332 | 1.64 | 26,784 |
| 2021-08-23 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 46.54 | 465,400 |
| 2021-08-23 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-08-19 | De Greef Roderick (CFO) | Sale | 12,000 | 45.12 | 541,440 |
| 2021-08-18 | Schick Joseph C (Director) | Sale | 625 | 44.11 | 27,568 |
| 2021-08-18 | De Greef Roderick (CFO) | Sale | 22,239 | 44.70 | 993,972 |
| 2021-08-17 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 44.80 | 275,968 |
| 2021-08-17 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-08-17 | De Greef Roderick (CFO) | Sale | 12,000 | 44.81 | 537,720 |
| 2021-08-16 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 46.03 | 283,544 |
| 2021-08-16 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-08-16 | Hinson Andrew G (Director) | Sale | 2,500 | 44.51 | 111,275 |
| 2021-08-05 | Rice Michael (CEO) | Sale | 11,461 | 48.37 | 554,368 |
| 2021-08-05 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-08-03 | Rice Michael (CEO) | Sale | 11,461 | 48.26 | 553,107 |
| 2021-08-03 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-07-26 | Schulz Marcus (Chief Revenue Officer) | Sale | 4,919 | 46.13 | 226,913 |
| 2021-07-26 | Foster Karen A. (Chief Quality Officer) | Sale | 16,333 | 45.24 | 738,904 |
| 2021-07-26 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,333 | 1.64 | 26,786 |
| 2021-07-21 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 8,854 | 45.61 | 403,830 |
| 2021-07-21 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 8,854 | 1.64 | 14,520 |
| 2021-07-20 | Aebersold Sarah (VP, Global Human Resources) | Sale | 1,059 | 45.10 | 47,760 |
| 2021-07-20 | Schulz Marcus (Chief Revenue Officer) | Sale | 2,539 | 45.10 | 114,508 |
| 2021-07-19 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 43.85 | 438,500 |
| 2021-07-19 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-07-16 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 44.04 | 271,286 |
| 2021-07-16 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-07-15 | Berard Todd (Chief Marketing Officer) | Sale | 6,165 | 42.74 | 263,492 |
| 2021-07-15 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,165 | 1.64 | 10,110 |
| 2021-07-15 | Hinson Andrew G (Director) | Sale | 2,500 | 44.44 | 111,100 |
| 2021-07-08 | Schulz Marcus (Chief Revenue Officer) | Sale | 240 | 45.73 | 10,976 |
| 2021-07-08 | Rice Michael (CEO) | Sale | 11,464 | 46.15 | 529,063 |
| 2021-07-08 | Rice Michael (CEO) | Option Ex | 11,464 | 1.64 | 18,800 |
| 2021-07-06 | Rice Michael (CEO) | Sale | 11,461 | 46.28 | 530,415 |
| 2021-07-06 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-06-29 | De Greef Roderick (CFO) | Sale | 685 | 43.75 | 29,968 |
| 2021-06-21 | Foster Karen A. (Chief Quality Officer) | Sale | 16,332 | 42.79 | 698,846 |
| 2021-06-21 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,332 | 1.64 | 26,784 |
| 2021-06-16 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 39.26 | 241,841 |
| 2021-06-16 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-06-15 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 39.38 | 242,580 |
| 2021-06-15 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-06-15 | Hinson Andrew G (Director) | Sale | 2,500 | 38.35 | 95,875 |
| 2021-06-10 | Rice Michael (CEO) | Sale | 11,461 | 36.47 | 417,982 |
| 2021-06-10 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-06-08 | Rice Michael (CEO) | Sale | 11,461 | 35.54 | 407,323 |
| 2021-06-08 | Rice Michael (CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-05-28 | Foster Karen A. (Chief Quality Officer) | Sale | 264 | 33.87 | 8,941 |
| 2021-05-28 | Rice Michael (CEO) | Sale | 802 | 33.87 | 27,163 |
| 2021-05-24 | Foster Karen A. (Chief Quality Officer) | Sale | 16,332 | 31.44 | 513,478 |
| 2021-05-24 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,332 | 1.64 | 26,784 |
| 2021-05-24 | Schick Joseph C (Director) | Sale | 1,250 | 31.61 | 39,512 |
| 2021-05-19 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 31.45 | 314,500 |
| 2021-05-19 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-05-17 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 30.12 | 301,200 |
| 2021-05-17 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-05-17 | Hinson Andrew G (Director) | Sale | 2,500 | 29.06 | 72,650 |
| 2021-05-14 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 29.68 | 182,828 |
| 2021-05-14 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-05-13 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 29.52 | 181,843 |
| 2021-05-13 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-04-21 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 32.26 | 322,600 |
| 2021-04-21 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-04-21 | Hinson Andrew G (Director) | Option Ex | 10,714 | 1.12 | 11,999 |
| 2021-04-20 | Schulz Marcus (Chief Revenue Officer) | Sale | 650 | 32.10 | 20,865 |
| 2021-04-19 | Foster Karen A. (Chief Quality Officer) | Sale | 16,332 | 32.58 | 532,096 |
| 2021-04-19 | Foster Karen A. (Chief Quality Officer) | Option Ex | 16,332 | 1.64 | 26,784 |
| 2021-04-19 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 10,000 | 32.62 | 326,200 |
| 2021-04-19 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.64 | 16,400 |
| 2021-04-16 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 33.38 | 205,620 |
| 2021-04-16 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-04-15 | Berard Todd (Chief Marketing Officer) | Sale | 6,160 | 33.76 | 207,961 |
| 2021-04-15 | Berard Todd (Chief Marketing Officer) | Option Ex | 6,160 | 1.64 | 10,102 |
| 2021-04-15 | Hinson Andrew G (Director) | Sale | 2,500 | 33.80 | 84,500 |
| 2021-04-15 | De Greef Roderick (CFO & COO) | Sale | 5,000 | 33.69 | 168,450 |
| 2021-04-14 | De Greef Roderick (CFO & COO) | Sale | 5,000 | 33.83 | 169,150 |
| 2021-04-13 | De Greef Roderick (CFO & COO) | Sale | 10,919 | 35.08 | 383,038 |
| 2021-04-13 | De Greef Roderick (CFO & COO) | Option Ex | 10,919 | 1.70 | 18,529 |
| 2021-04-08 | Rice Michael (President & CEO) | Sale | 11,461 | 35.32 | 404,802 |
| 2021-04-08 | Rice Michael (President & CEO) | Option Ex | 11,461 | 1.64 | 18,796 |
| 2021-04-01 | Foster Karen A. (Chief Quality Officer) | Sale | 3,414 | 36.53 | 124,713 |
| 2021-04-01 | Foster Karen A. (Chief Quality Officer) | Option Ex | 8,797 | .00 | 0 |
| 2021-04-01 | Berard Todd (Chief Marketing Officer) | Sale | 2,825 | 36.53 | 103,197 |
| 2021-04-01 | Berard Todd (Chief Marketing Officer) | Option Ex | 7,279 | .00 | 0 |
| 2021-04-01 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Sale | 4,020 | 36.53 | 146,850 |
| 2021-04-01 | Mathew Aby J. (Exec VP & Chief Scientific Officer) | Option Ex | 10,358 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLFS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biolife Solutions Inc (symbol BLFS, CIK number 834365) see the Securities and Exchange Commission (SEC) website.